Tech Company Financing Transactions
Auxilius Pharma Funding Round
CofounderZone joined a $1 million Seed capital raise for Auxilius Pharma. The round was announced on 6/14/2023.
Transaction Overview
Company Name
Announced On
6/14/2023
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
CofounderZone (Lead Investor)
Proceeds Purpose
The company intends to use the funds for developing its lead asset, AUX-001, an innovative new medication for treating chronic-stable angina pectoris in the US, a condition affecting 11 million Americans over the age of 20.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY 10001
USA
New York, NY 10001
USA
Phone
Website
Email Address
Overview
Auxilius Pharma is an emerging specialized pharmaceutical company with a focus on further developing and optimizing medications well established in some markets but not in the others, for the benefit of patients and to address major unmet needs in an increasingly cost conscious health care market environment. We are a versatile team with multifunctional healthcare experience in both the US and EU. We feature diverse backgrounds and strong core competencies in pharmaceutical marketing, drug development, pharmacology, health care management, corporate finance, and asset management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jedrzej Litwiniuk
Chief Marketing Officer
Uwe Tigör
Browse more venture capital transactions:
Prev: 6/14/2023: Canva venture capital transaction
Next: 6/14/2023: Million Victories venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs